Literature DB >> 2824814

Adenovirus early region 4 is required for efficient virus particle assembly.

B Falgout1, G Ketner.   

Abstract

H2dl807, a defective deletion mutant of human adenovirus type 2 lacking parts of early regions 3 and 4 and all of late region 5, was severely defective for virus particle assembly on HeLa cells, producing about 1% of the normal yield of particles. On Vero cells, H2dl807 produced only 5% as many particles as wild type, while on W162 cells, a Vero cell derivative which supports the growth of early region 4 mutants, H2dl807 produced nearly 40% of the wild-type level of particles. Two other defective deletion mutants, H2dl802 and H5dl1021, which lack parts of early region 3 and which are incapable of making fiber, the product of late region 5, were wild type for virus assembly. These data suggest that the cause of the assembly defect of H2dl807 is the lack of a diffusible early region 4 product. H2dl807-infected Vero cells accumulated nearly wild-type amounts of viral late proteins in the nucleus and cytoplasm. Thus, the defect of the mutant in assembly on Vero cells is not due to a general lack of late proteins. Finally, the fact that H2dl802 and H5dl1021 make wild-type amounts of virus particles suggests that fiber is not essential for adenovirus assembly.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824814      PMCID: PMC255990          DOI: 10.1128/JVI.61.12.3759-3768.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Intermediates in adenovirus assembly.

Authors:  B Edvardsson; E Everitt; H Jörnvall; L Prage; L Philipson
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

2.  A circula DNA-protein complex from adenoviruses.

Authors:  A J Robinson; H B Younghusband; A J Bellett
Journal:  Virology       Date:  1973-11       Impact factor: 3.616

3.  Assembly intermediates among adenovirus type 5 temperature-sensitive mutants.

Authors:  B Edvardsson; S Ustacelebi; J Williams; L Philipson
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

4.  Nucleotide sequence of adenovirus 2 DNA fragment encoding for the carboxylic region of the fiber protein and the entire E4 region.

Authors:  J Hérissé; M Rigolet; S D de Dinechin; F Galibert
Journal:  Nucleic Acids Res       Date:  1981-08-25       Impact factor: 16.971

5.  Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying mutations near the right end of the viral genome.

Authors:  S S Challberg; G Ketner
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

6.  Adenovirus type 2 assembly analyzed by reversible cross-linking of labile intermediates.

Authors:  J C D'Halluin; G R Martin; G Torpier; P A Boulanger
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

7.  Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome.

Authors:  T J Kelly; A M Lewis
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

8.  Morphogenesis of human adenovirus type 2 studied with fiber- and fiber and penton base-defective temperature-sensitive mutants.

Authors:  J C D'Halluin; M Milleville; G R Martin; P Boulanger
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

9.  Temperature-sensitive mutant of adenovirus type 2 blocked in virion assembly: accumulation of light intermediate particles.

Authors:  J C D'Halluin; M Milleville; P A Boulanger; G R Martin
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  11 in total

1.  Defective synthesis of early region 4 mRNAs during abortive adenovirus infections in monkey cells.

Authors:  D Ross; E Ziff
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Adenovirus early region 4 stimulates mRNA accumulation via 5' introns.

Authors:  K Nordqvist; G Akusjärvi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.

Authors:  V Legrand; D Spehner; Y Schlesinger; N Settelen; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

4.  Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.

Authors:  J F Dedieu; E Vigne; C Torrent; C Jullien; I Mahfouz; J M Caillaud; N Aubailly; C Orsini; J M Guillaume; P Opolon; P Delaere; M Perricaudet; P Yeh
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids.

Authors:  G Ketner; E Bridge; A Virtanen; C Hemström; U Pettersson
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

6.  Characterization of adenovirus particles made by deletion mutants lacking the fiber gene.

Authors:  B Falgout; G Ketner
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

7.  Redundant control of adenovirus late gene expression by early region 4.

Authors:  E Bridge; G Ketner
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection.

Authors:  M M Huang; P Hearing
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

9.  Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.

Authors:  P Yeh; J F Dedieu; C Orsini; E Vigne; P Denefle; M Perricaudet
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal.

Authors:  Yadvinder S Ahi; Ahmed O Hassan; Sai V Vemula; Kunpeng Li; Wen Jiang; Guang Jun Zhang; Suresh K Mittal
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.